INS and COVID-19: Furthermore, due to dyslipidemia, there is an increase in triglycerides, free fatty acids, inflammatory cytokines, insulin resistance, and C-reactive protein (CRP), which increase the risk of severe COVID-19 cases and mortality [2,3,4,68].